Results 301 to 310 of about 6,006,073 (362)

Therapeutic frontiers in ALS: iPSC-based drug discovery, cell therapy, and gene therapy-Advances through 2026. [PDF]

Regen Ther
Morimoto S, Kato C, Takahashi S, Okano H.   +3 more
europepmc   +1 more source

Combining Fluorescence and Magnetic Resonance Imaging in Drug Discovery-A Review. [PDF]

Pharmaceuticals (Basel)
Smolak B, Dynarowicz K, Bartusik-Aebisher D, Henrykowska G, Aebisher D, Guz W.   +5 more
europepmc   +1 more source

Surface Plasmon Resonance as a Tool in Antiviral Drug Discovery Research. [PDF]

Biosensors (Basel)
Wegrzyn KE, Matsoukas JM.
europepmc   +1 more source

Unfreezing structural biology for drug discovery. [PDF]

Nat Chem Biol
Stachowski TR, Fischer M.
europepmc   +1 more source

Unleashing the power of DNA-encoded libraries for challenging targets in drug discovery. [PDF]

Pharm Sci Adv
Du N, Li Y, Lou Q, Zhang G, Li Y, Li Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Drug Discovery

Current Pharmaceutical Design, 2022

openaire   +3 more sources

Chronicles in Drug Discovery

Drug News & Perspectives, 2005
New brief reports this month include: Strategies for Duchenne Muscular Dystrophy: Various approaches are being explored to abate the dystrophic process including cellular therapies (transplanting stem cells or myogenic precursors into muscles), molecular approaches (delivering a functional or correcting the mutant dystrophin gene), such as MyoDys ...
V K, Khurdayan, J, Bozzo, J R, Prous
openaire   +4 more sources